WPRIM Management System> DCMS> Blood Research> 2019> 54> 3

Volume: 54 Issue: 3

1. Successful treatment of non-IgM lymphoplasmacytic lymphoma by bortezomib-containing regimen: case reports and review of literature Page:236—240
2. Characteristics and survival of patients with atypical chronic myeloid leukemia Page:233—236
3. Bone marrow metastasis of small cell lung carcinoma with spontaneous tumor lysis syndrome without hepatic metastasis at diagnosis: first case report in Korea and review of literature Page:231—233
4. High-grade nodal marginal zone lymphoma with diffuse bone marrow involvement and IgM-type monoclonal paraproteinemia: a case report and review of the literature Page:229—231
5. Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura Page:218—228
6. Clinical features and treatment outcomes of Hodgkin lymphoma: A retrospective review in a Malaysian tertiary hospital Page:210—217
7. The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A Page:204—209
8. Subgroup analysis of a phase 2/3 study of rurioctocog alfa pegol in patients with severe hemophilia A: efficacy and safety in previously treated Korean patients Page:198—203
9. Favorable long-term survival using consolidation chemotherapy without allogeneic hematopoietic cell transplantation for acute myeloid leukemia with wild-type NPM1 without FLT3-ITD Page:189—197
10. Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study Page:175—180
11. Mesenchymal stem cells in acute myeloid leukemia: a focus on mechanisms involved and therapeutic concepts Page:165—174
12. Neutrophil-erythrocyte rosettes in direct antiglobulin test-negative autoimmune hemolytic anemia Page:164—164
13. A case of follicular lymphoma accompanied with chylous ascites Page:163—163
14. Chronicles of blood morphology associated with steroid use Page:162—162
15. Optimizing carfilzomib use in multiple myeloma treatment Page:159—161

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.